Research Progress on Traditional Chinese Medicines for Reversing Bacterial Resistance and Their Mechanisms of Action

DOI: 10.12201/bmr.202503.00056

•  

  Abstract: The escalating challenge of bacterial drug resistance has emerged as a critical global public health concern. Traditional Chinese Medicine (TCM), characterized by its multi-target mechanisms of action and low toxicity profile, has progressively become a pivotal research direction for reversing antibiotic resistance. This paper systematically reviews recent advances in molecular mechanisms underlying TCM-mediated regulation of drug-resistant bacteria, with emphasis on six key pathways: 1) suppression of resistance gene mutations through regulation of RecA protein activity; 2) inhibition of horizontal transfer of resistance genes via interference with plasmid conjugation and transformation; 3) enhancement of bacterial outer membrane permeability; 4) functional inhibition of efflux pumps exemplified by the AcrAB-TolC system; 5) elimination of resistance plasmids via activation of the Hok/Sok system; and 6) inhibition of extended-spectrum β-lactamase activity, particularly targeting CTX-M-15 enzymes. Clinical evidence supporting the synergistic effects of TCM-antibiotic combination therapies is critically analyzed, along with discussion of their clinical potential and limitations. Current research gaps are identified, including standardization deficiencies in TCM components, insufficient elucidation of multi-target mechanisms, and potential hepatotoxicity risks. Future directions are proposed, encompassing nanotechnology-enhanced drug delivery systems, multi-omics analysis to elucidate interaction networks, and international standardization initiatives. This study provides both theoretical foundations and practical references for advancing TCM development and clinical translation in antimicrobial resistance management.

  Key words: traditional Chinese medicine; active ingredients; antibiotic-resistant bacteria; molecular mechanisms; synergistic effects

  Submit time: 19 March 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Zheyi Fang, Wenjun Zhu, Jiayan Huang. A Bibliometric Analysis on Global Research Activities of Antimicrobial Resistance. 2022. doi: 10.12201/bmr.202207.00021

  CHENG Yanyan, HE Jiayu, RUAN Yuhe, LI Zixin, ZHANG Ying. Exploration of the medication rules and mechanism of traditional Chinese medicine in treatment of cancer-related insomnia based on data mining, network pharmacology and molecular dynamics simulation.. 2025. doi: 10.12201/bmr.202510.00051

  Huang yin-tao, Shou jia-bao. The Distribution of Pathogens and Antibiotic Resistance in Necrotizing Fasciitis in the Central Minority Areas of Guangxi. 2024. doi: 10.12201/bmr.202412.00045

  LIANG Ningjuan, WU Ting, YU Dandan, JIANG Xiaohan, TENG Jingjing. Effective exploration of the toxicity and molecular mechanisms of plasticisers in pulmonary fibrosis by network toxicology and molecular docking strategies: an example of butylbenzyl phthalate. 2025. doi: 10.12201/bmr.202504.00004

  Lei Genping, #Wang Ting, Dong Sheng, Xie Jiongdong, Lu Xian, Yang Dong. Safety and effectiveness of traditional Chinese medicine compound in treating idiopathic membranous Nephropathy Network Meta-analysis. 2024. doi: 10.12201/bmr.202412.00003

  Jiang Tao. Research Progress on the Treatment of Knee Osteoarthritis by Regulating Relevant Signal Pathways with Traditional Chinese Medicine. 2025. doi: 10.12201/bmr.202509.00021

  LIU Zheng-qiang, ZHANG Ke-jing, ZHANG Wen-chun. Research Progress on the Mechanisms of Insomnia. 2025. doi: 10.12201/bmr.202510.00063

  ChenJin. Multi-target Mechanisms of Berberine in Blood Glucose Regulation and Research Progress in Prevention and Treatment of Type 2 Diabetes Mellitus. 2025. doi: 10.12201/bmr.202510.00049

  WU Xiayang. The mechanisms of action of SGLT2i in the treatment of heart failure and recent research advances. 2025. doi: 10.12201/bmr.202507.00052

  Research Progress on Integrated Traditional Chinese and Western Medicine for Chemotherapy-Induced Myelosuppression in Gastrointestinal Malignancies. 2025. doi: 10.12201/bmr.202506.00008

• ID	Submit time	Number	Download
  1	2025-02-27	10.12201/bmr.202503.00056V1	Download

• Public  Anonymous  To author only Submit Comments